Sudden death remains a public health challenge, despite substantial progress in identifying associated clinical, structural, and genetic factors,[@bib1], [@bib2] with an annual incidence ranging from 150,000 to 400,000 in the United States. Attempts to further elucidate characteristics predictive of sudden death are therefore crucial for identifying populations at risk and instituting preventive measures.

The association between high total cholesterol (TC) levels,[@bib3] high low-density lipoprotein cholesterol (LDL-C) levels,[@bib4] high triglyceride (TG) levels,[@bib5] low high-density lipoprotein cholesterol (HDL-C) levels, and cardiovascular risk is well known. However, few studies have examined the relationship between lipid measurements and sudden death, with varied conclusions. Large prospective cohort studies have found both an elevated[@bib6], [@bib7] and a similar[@bib8] risk of sudden death associated with higher baseline TC measurements. Postmortem studies have reported higher levels of remnant lipoprotein particles (RLPs) in cases of sudden death.[@bib9]

There is a lack of comprehensive data on lipid measurements in nonelderly adults temporally closer to death. We aimed to fill this gap by conducting a case-control study comparing lipid profiles of out-of-hospital sudden unexpected death (OHSUD) cases with available lipid profiles with those who did not experience sudden unexpected death within a population-based case-control study from Wake County, a socioeconomically and racially diverse region in North Carolina. We hypothesized that sudden death cases would have a similar or less favorable lipid profile relative to control subjects.

Patients and Methods {#sec1}
====================

The Sudden Unexpected Death in North Carolina (SUDDEN) study is an ongoing population-based registry of adjudicated premature OHSUD cases in North Carolina. The SUDDEN study aims to capture all natural OHSUDs and includes sudden death cases regardless of whether the fatal event was witnessed and/or resuscitation attempted by using criteria similar to those of the Resuscitation Outcomes Consortium for out-of-hospital cardiac arrest.[@bib10] The pilot study was conducted from March 1, 2013, through February 28, 2015, in Wake County, NC, a diverse and predominantly urban region (2015 population estimate: 1,024,198; 21.3% blacks[@bib11]).

 {#sec1.1}

### Out-of-Hospital Sudden Unexpected Death Cases {#sec1.1.1}

Cases of OHSUD were adjudicated according the pilot criteria for the SUDDEN study described elsewhere.[@bib12] We briefly present them here. All emergency medical services (EMS)--attended out-of-hospital deaths occurring from March 1, 2013, through February 28, 2015, in North Carolina residents aged 18 to 64 years were queried from Wake County EMS patient care reporting software. We then excluded those not "free living" such as inmates of prisons/correctional institutions, residents of skilled nursing facilities/hospice, and individuals with "do not resuscitate" orders. Those who had nonnatural/violent deaths were also excluded using information from EMS narratives, medical examiner, and/or autopsy reports ([Figure 1](#fig1){ref-type="fig"}). For all included cases, we requested medical records of 5 years preceding death from area health care providers. A committee of cardiologists reviewed all records acquired to adjudicate the sudden and unexpected nature of death for a case. For the present study, we included only adjudicated OHSUD cases with 1 or more lipid panel within their medical records.Figure 1Ascertainment of OHSUD cases. DNR = do not resuscitate; EMS = emergency medical services; HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol; OHSUD = out-of-hospital sudden unexpected death; TC = total cholesterol; TG = triglyceride.

### Control Group {#sec1.1.2}

A control group was formed by randomly sampling 15,000 patients from the Carolina Data Warehouse for Health (CDW), a data repository containing electronic health records of 18 hospitals and practices within the University of North Carolina Healthcare Systems.[@bib13] This sample size was chosen by estimating the number of patients required for sufficient Wake County residents to be randomly included in the sample and serve as controls in an approximately 3:1 control-case ratio for various analyses. Patients were eligible for selection if they had visited University of North Carolina Healthcare Systems' hospital systems or affiliate providers from March 1, 2013, through February 28, 2015 (index visit), and were aged 18 to 64 years during the index visit. We obtained 5 years of CDW electronic medical records before the index visit of selected patients. Patients were excluded if their home address was not in Wake County, NC (n=9710), or if they did not have any medical history recorded within the previous 5 years in CDW (n=590). We excluded patients with documented discharge to a correctional institution, law enforcement, skilled nursing facility, assisted care facility, long-term acute care facility, or hospice (n=592). Finally, we included in our analysis only patients with 1 or more lipid measurement in 5 years preceding their index visit (n=968).

Data Ascertainment {#sec1.2}
------------------

For OHSUD cases and controls, we obtained age at death or index visit, sex, and race from death certificates and electronic health care records, respectively.

Dates of lipid measurements and values of TC, TG, HDL-C, and LDL-C were abstracted from the most recent laboratory reports or health care provider notes for cases; for controls, the most recent lipid measurements within the electronic record preceding the index visit were used. If, for any subject, a single lipid panel had only 3 of 4 lipid measures available, we used the Friedewald equation (LDL=(TC--HDL--TG)/5)[@bib14] to estimate the missing value, with the LDL-C value calculated only if a TG value was 400 mg/dL or less (to convert to mmol/L, multiply by 38.67) and the TG value calculated only if a calculated LDL value was available. For all subjects, we calculated non-HDL values using the following equation: non-HDL=TC--HDL-C. We also derived the TG/HDL-C ratio, TC/HDL-C ratio, and LDL-C/HDL-C ratio.

We obtained heart rate, systolic blood pressure, diastolic blood pressure, and body mass index (BMI; calculated as the weight in kilograms divided by the height in meters squared) from the most recent record available. Body mass index was either directly abstracted or calculated from abstracted height and weight.

For cases, comorbid medical conditions such as diabetes mellitus, dyslipidemia, hypertension, and coronary artery disease were abstracted from medical records according to the presence of diagnostic terms, whereas for controls, *International Classification of Diseases, Ninth Revision*/*International Statistical Classification of Diseases, 10th Revision* codes were used ([Supplemental Table 1](#appsec1){ref-type="sec"}, available online at <http://www.mcpiqojournal.org>). We also recorded the use of lipid-lowering medication by searching the medical record for generic and brand medication names.

Reliability of the abstraction process for OHSUD cases was ensured via blind reabstraction of a 10% sample by a quality officer. Electronic record abstraction queries for controls were developed by B.M.B. and verified by N.H. and G.J.

Statistical Analyses {#sec1.3}
--------------------

Differences were tested using a 2-sided *t* test for continuous variables and Pearson chi-square test for categorical variables. We used multiple linear regression to assess the unadjusted (model 1) and age- and sex-adjusted (model 2) mean differences in lipid measures between cases and controls. We performed logistic regression to calculate the unadjusted (model 1) and age- and sex-adjusted (model 2) odds of OHSUD associated with each lipid measurement. We additionally included another model (model 3), which adjusts for age, sex, BMI, diabetes mellitus, and interaction between each lipid measure and lipid-lowering medication use. For multivariate analysis, we partitioned TC, TG, HDL-C, LDL-C, and non-HDL values into quartiles (lowest quartile as reference). For all analysis pertaining to LDL-C, subjects with TG levels greater than 400 mg/dL were excluded if the direct LDL-C value was missing. For all analyses, we used a significance level of .05 and SAS 9.4 (SAS Institute Inc).

To test the robustness of our conclusions, we defined a second control group using 18- to 64-year-old participants from the 2009 to 2010 National Health and Nutrition Examination Survey (NHANES) who were confirmed alive 1 year after the survey and had a TC, TG, HDL-C, or LDL-C measurement (n=4571).[@bib15] All information was obtained from publicly available databases.[@bib15] National Health and Nutrition Examination Survey methods are detailed elsewhere.[@bib16] Briefly, lipid measurements and BMI of participating subjects were recorded during clinical examinations; comorbid medical conditions were self-reported.

Results {#sec2}
=======

From March 1, 2013, through February 28, 2015, we identified 139 OHSUD cases with at least 1 lipid measurement available in clinical records. After exclusions, we identified 968 controls. As presented in [Table 1](#tbl1){ref-type="table"}, OHSUD cases were older (54.8±7.6 years vs 47.2±8.7 years; *P*\<.001), less likely to be female (30.9% \[n= 43\] vs 55.7% \[n=539\]; *P*\<.01), and more likely to be black (36.7% \[n=51\] vs 20.4% \[n=197\]; *P*\<.05).Table 1Population Characteristics of OHSUD Cases, Local Controls, and 2009-2010 NHANES Participants[a](#tbl1fna){ref-type="table-fn"}^,^[b](#tbl1fnb){ref-type="table-fn"}^,^[c](#tbl1fnc){ref-type="table-fn"}^,^[d](#tbl1fnd){ref-type="table-fn"}^,^[e](#tbl1fne){ref-type="table-fn"}CharacteristicOHSUD cases (n=139)Local controls (n=968)NHANES participants (n=4571)Age (y)54.8±7.647.2±8.740.2±13.7[f](#tbl1fnf){ref-type="table-fn"}Sex: female43 (30.9)539 (55.7)2374 (51.9)[f](#tbl1fnf){ref-type="table-fn"}Race[f](#tbl1fnf){ref-type="table-fn"} White86 (61.9)628 (64.9)[f](#tbl1fnf){ref-type="table-fn"}2003 (43.8) Black51 (36.7)197 (20.4)[f](#tbl1fnf){ref-type="table-fn"}834 (18.2) Asian2 (1.4)32 (3.31)-- Other1 (0.7)20 (5.7)275 (6) Hispanic----1459 (31.9)American Indian or Alaska Native--3 (0.3)-- Refused--7 (0.7)-- Unknown--51 (5.3)--Heart rate (beats/min)78±11.476±13.577.2±14.5Systolic blood pressure (mm Hg)132.6±21.5125.7±16.8[f](#tbl1fnf){ref-type="table-fn"}130.4±25.6Diastolic blood pressure (mm Hg)80.9±13.878±10.8[g](#tbl1fng){ref-type="table-fn"}79.4±15.2BMI (kg/m^2^)31.3±9.730±7.129±7[f](#tbl1fnf){ref-type="table-fn"}Dyslipidemia103 (74.1)348 (36)[f](#tbl1fnf){ref-type="table-fn"}1034 (38)[f](#tbl1fnf){ref-type="table-fn"}Dyslipidemia diagnosis or LL medication use104 (74.8)371 (40.1)[f](#tbl1fnf){ref-type="table-fn"}1034 (37.8)[f](#tbl1fnf){ref-type="table-fn"}Use of LL medication60 (43.2)265 (27.4)[f](#tbl1fnf){ref-type="table-fn"}493 (78.6)[f](#tbl1fnf){ref-type="table-fn"}Diabetes mellitus61 (43.9)164 (16.9)[f](#tbl1fnf){ref-type="table-fn"}335 (7.3)[f](#tbl1fnf){ref-type="table-fn"}Hypertension110 (79.1)360 (37.2)[f](#tbl1fnf){ref-type="table-fn"}1074 (23.5)[f](#tbl1fnf){ref-type="table-fn"}Coronary artery disease40 (28.8)42 (4.3)[f](#tbl1fnf){ref-type="table-fn"}161 (3.7)[f](#tbl1fnf){ref-type="table-fn"}Annual health care encounters5.8±65.0±6.13.8±4[f](#tbl1fnf){ref-type="table-fn"}[^1][^2][^3][^4][^5][^6][^7]

Although the mean BMI was similar between cases and controls, the prevalence of comorbidities was higher in OHSUD cases, including dyslipidemia (74.1% \[n=103\] vs 36% \[n=348\]; *P*\<.001), diabetes mellitus (43.9% \[n=61\] vs 16.9% \[n=164\]; *P*\<.001), hypertension (79.1% \[n=110\] vs 37.2% \[n=360\]; *P*\<.001), coronary artery disease (28.8% \[n=40\]vs 4.3% \[n=42\]; *P*\<.001), and use of lipid-lowering medication (43.2% \[n=60\] vs 27.4% \[n=265\]; *P*\<.001). Notably, both cases and controls had a similar average number of health care encounters in the preceding year ([Table 1](#tbl1){ref-type="table"}).

The unadjusted mean TC (170.3±52.2 mg/dL vs 188.9±39.7 mg/dL; *P*\<.001), LDL-C (90.9±39.6 mg/dL vs 109.6±35.2 mg/dL; *P*\<.001), and non-HDL (121.6±49.8 mg/dL vs 134.3±39.6 mg/dL; *P*\<.001) levels were all significantly lower in OHSUD cases than in controls ([Table 2](#tbl2){ref-type="table"}). Although the unadjusted mean HDL-C level was significantly lower in cases than in controls (48.3±20.2 mg/dL vs 54.6±17.8 mg/dL; *P*\<.001), there was no significant difference in unadjusted mean TG level. The TG/HDL-C ratio was the only ratio examined that was significantly higher in OHSUD cases (4.7±7 vs 3±2.7; *P*\<.001). Differences between TC, LDL-C, and non-HDL levels remained statistically significant after adjustment for age and sex ([Table 2](#tbl2){ref-type="table"}).Table 2Lipid Measurements in OHSUD Cases, Local Controls, and NHANES Participants[a](#tbl2fna){ref-type="table-fn"}^,^[b](#tbl2fnb){ref-type="table-fn"}^,^[c](#tbl2fnc){ref-type="table-fn"}^,^[d](#tbl2fnd){ref-type="table-fn"}^,^[e](#tbl2fne){ref-type="table-fn"}VariableOHSUD cases (n=139)Local controls (n=968)NHANES participants (n=4571)TC level (mg/dL)170.3±52.2188.9±39.7[f](#tbl2fnf){ref-type="table-fn"}194.9±41.5[f](#tbl2fnf){ref-type="table-fn"}TG level (mg/dL)170.9±210.6135.8±90[g](#tbl2fng){ref-type="table-fn"}129.4±120.7[f](#tbl2fnf){ref-type="table-fn"}HDL-C level (mg/dL)48.3±20.254.6±17.851.9±16.1[f](#tbl2fnf){ref-type="table-fn"}LDL-C (mg/dL)90.9±39.6109.6±35.2[f](#tbl2fnf){ref-type="table-fn"}116.1±34.8[f](#tbl2fnf){ref-type="table-fn"}Non--HDL-C level (mg/dL)121.6±49.8134.3±39.6[f](#tbl2fnf){ref-type="table-fn"}143±42.5[f](#tbl2fnf){ref-type="table-fn"}TG/HDL-C ratio4.7±73±2.7[f](#tbl2fnf){ref-type="table-fn"}3.1±5.1[f](#tbl2fnf){ref-type="table-fn"}TC/HDL-C ratio4±1.83.8±1.34.1±1.6LDL-C/HDL-C ratio2.1±1.22.2±1[g](#tbl2fng){ref-type="table-fn"}2.4±1[f](#tbl2fnf){ref-type="table-fn"}[^8][^9][^10][^11][^12][^13][^14]

The odds of OHSUD were elevated per unit increase in TG/HDL-C ratio in models that were unadjusted (model 1: odds ratio \[OR\], 1.10; 95% CI, 1.05-1.15) and age and sex adjusted (model 2: OR, 1.08; 95% CI, 1.03-1.12) ([Table 3](#tbl3){ref-type="table"}).Table 3Odds Ratios (95% CIs) for OHSUD Associated With Various Lipid Measurements by Univariate and Multivariate Analyses[a](#tbl3fna){ref-type="table-fn"}^,^[b](#tbl3fnb){ref-type="table-fn"}VariableModel 1[c](#tbl3fnc){ref-type="table-fn"}Model 2Model 3TC level (highest vs lowest quartile)0.4 (0.25-0.65)0.43 (0.25-0.74)0.45 (0.22-0.95)TG level (highest vs lowest quartile)1.00 (1.00-1.00)1.00 (1-1.00)0.73 (0.34-1.59)HDL-C level (highest vs lowest quartile)0.43 (0.27-0.70)0.64 (0.37-1.13)0.77 (0.37-1.62)LDL-C (highest vs lowest quartile)0.30 (0.18-0.50)0.32 (0.18-0.56)0.36 (0.17-0.77)Non--HDL-C (highest vs lowest quartile)0.46 (0.28-0.73)0.45 (0.27-0.75)0.44 (0.21-0.93)TG/HDL-C ratio (per unit increase)1.10 (1.05-1.15)1.08 (1.03-1.12)1.05 (1.01-1.10)TC/HDL-C ratio (per unit increase)1.12 (0.99-1.26)1.04 (0.90-1.19)1.01 (0.83-1.23)LDL-C/HDL-C ratio (per unit increase)0.94 (0.78-1.13)0.88 (0.72-1.07)0.85 (0.65-1.12)[^15][^16][^17]

The odds of OHSUD were lower for the highest quartile of TC values in both model 1 (OR, 0.4; 95% CI, 0.25-0.65) and model 2 (OR, 0.43; 95% CI, 0.25-0.74). The highest quartile of LDL-C values was also associated with lower odds of OHSUD (model 1: OR, 0.30; 95% CI, 0.18-0.50; model 2: OR, 0.32; 95% CI, 0.18-0.56). Similarly, the highest quartile of non-HDL values was associated with lower odds of OHSUD (model 1: OR, 0.46; 95% CI, 0.28-0.73; model 2: OR, 0.45; 95% CI, 0.24-0.75). Similar trends were observed even after additional adjustment for plausible confounders (model 3) ([Figure 2](#fig2){ref-type="fig"}).Figure 2Odds ratios (95% CIs) of out-of-hospital sudden unexpected death associated with various lipid measures, using local controls as the reference group. Odds ratios (95% CIs) depicted are obtained from model 3, which is adjusted for age, sex, body mass index, diabetes mellitus, and interaction between respective lipid measure and lipid-lowering medication use. For the TG/HDL-C ratio, model 3 adjusts for age, sex, body mass index, and diabetes mellitus. For the LDL-C level and LDL-C/HDL-C ratio, model 3 additionally adjusts for TG level (as continuous variable). HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol; OR = odds ratio; TC = total cholesterol; TG = triglyceride.

We compared OHSUD cases with NHANES participants (n=4571) to serve as sensitivity analyses. As seen in [Tables 1](#tbl1){ref-type="table"} and [2](#tbl2){ref-type="table"}, comparison trends between OHSUD cases and NHANES participants were similar to those seen in Wake County (local) controls.

By finding a lower TC level, an LDL-C level in OHSUD cases was unanticipated. We therefore performed an array of sensitivity analyses. Excluding direct LDL-C values, which are typically numerically lower than measured LDL values, did not yield results markedly different from our main results ([Supplemental Table 2](#appsec1){ref-type="sec"}, available online at <http://www.mcpiqojournal.org>).

Although race was excluded from the analytical models given the variable race distribution of subjects with few nonblack, nonwhite, or unknown subjects among OHSUD cases (n=3) and many among controls (n=113), adjusting for race in a sensitivity analysis did not markedly alter our results ([Supplemental Table 3](#appsec1){ref-type="sec"}, available online at <http://www.mcpiqojournal.org>).

When stratified by age, although the odds of OHSUD associated with TC, HDL-C, LDL-C and non-HDL levels in those younger than 45 years differed significantly as compared with the overall results, the same odds in those 45 years or older were similar to the overall results ([Supplemental Table 4](#appsec1){ref-type="sec"}, available online at <http://www.mcpiqojournal.org>). The larger number of older OHSUD cases (≥45 years: n=123 vs \<45 years: n=16) may therefore be responsible for the overall lower levels of lipid measures. Notably, however, higher unadjusted odds of OHSUD associated with the TG/HDL-C ratio were seen in both age groups. When stratified by sex, the LDL-C level was associated with lower odds and the TG/HDL-C ratio with higher odds of OHSUD in both men and women ([Supplemental Table 5](#appsec1){ref-type="sec"}, available online at <http://www.mcpiqojournal.org>). Stratifying by a previous diagnosis of coronary artery disease also did not alter our findings ([Supplemental Table 6](#appsec1){ref-type="sec"}, available online at <http://www.mcpiqojournal.org>).

Discussion {#sec3}
==========

We characterized standard lipid profile measures in OHSUD cases and a geographically based control group of living individuals. We found that OHSUD cases had significantly lower mean TC, non--HDL-C, and, most notably, LDL-C levels than did controls at approximately 1 year from either death (cases) or index visit (controls). Lower levels of these components were unanticipatedly associated with higher odds of OHSUD even after multivariate adjustment. Although no meaningful trend could be delineated between OHSUD and TG or HDL-C levels individually, the mean TG/HDL-C ratio was found to be associated with higher odds of OHSUD.

To our knowledge we are the first study to have categorically studied lipid measurements within a few years of sudden death. Most prospective studies have reported baseline lipid measurements of sudden death cases, often decades preceding death. A 20-year follow-up of male Framingham Heart Study[@bib17] participants aged 45 to 74 years reported no association between cholesterol levels and sudden death, but a 38-year follow-up of 30- to 62-year-old female Framingham Heart Study participants[@bib18] reported an elevated risk of sudden death in women who had higher cholesterol levels. In contrast, the Honolulu Heart Study,[@bib6] the Paris Prospective Study,[@bib19] and the British Regional Heart Study[@bib7] all reported a significant association of cholesterol levels with the risk of sudden death in middle-aged men. Few studies have examined LDL-C levels in relationship to sudden death, but the Physicians' Health Study[@bib20] and Kuopio Ischemic Heart Disease Risk Factor Study[@bib21] both reported similar LDL-C levels in sudden death cases and participants who did not die suddenly during follow-up.

It is worth noting that despite the established association between lower LDL-C levels and reduced atherosclerosis, some studies have found inverse, U-shaped, and no association between TC or LDL-C level reduction and cardiovascular events[@bib22], [@bib23], [@bib24] in individuals older than 60 years. Similar findings in middle-aged individuals have been reported. The Atherosclerosis Risk in Communities Study reported a J-shaped relationship between all-cause mortality and LDL-C levels in participants with a mean age of 54 years at baseline during 10 years of follow-up.[@bib25] A U-shaped relationship between TC levels and all-cause mortality and a linearly increasing relationship between TC levels and coronary disease mortality were observed in 35- to 69-year-old Framingham Heart Study participants.[@bib26] Similarly, the Tecumseh Community Health Study found a low risk of all-cause mortality in 45- to 64-year-old subjects in the middle tertile of serum cholesterol levels but found cholesterol to be a significant predictor of fatal coronary heart disease.[@bib27]

The lower odds of OHSUD observed with higher quartiles of TC, LDL-C, and non-HDL values may indicate a lack of association between the traditional lipid cardiovascular risk factors and OHSUD. It may also be indicative of a residual sudden death risk in the community despite adequate control of TC and/or LDL-C levels with medication, as previously suggested.[@bib28]

High TG[@bib29] and low HDL[@bib30] levels, the hallmarks of combined dyslipidemia, are established predictors of adverse cardiovascular events, but their relationship to sudden death is largely inconclusive.[@bib19], [@bib21] However, studies have found a correlation between high levels of circulating free fatty acids and sudden death.[@bib31], [@bib32] As free fatty acids contribute to circulating TGs,[@bib33] this is a plausible biological pathway suggesting an association between elevated TG levels and sudden death. In this study, although OHSUD cases had higher unadjusted mean TG levels and lower unadjusted mean HDL-C levels, the difference was rendered insignificant on multivariate adjustment. However, the TG/HDL-C ratio was significantly higher in sudden death cases and this difference persisted even after adjustment for age, sex, and comorbid medical conditions. The TG/HDL-C ratio is increasingly recognized as an indicator of insulin resistance,[@bib34] a measure of atherogenicity representative of small dense LDL,[@bib35] an independent predictor of poor cardiac fitness[@bib36] and adverse cardiovascular events.[@bib37] The TG/HDL-C ratio serves as a marker of the complex interaction between circulating TG and HDL levels that results in increased circulating levels of RLPs, which are dense apolipoprotein E--rich catabolites of very low-density lipoproteins and chylomicrons. Remnant cholesterol, the cholesterol content of RLPs, has been identified as an independent indicator of cardiovascular risk in several studies[@bib38] including Framingham Heart Study[@bib39] and Honolulu Heart Study.[@bib40] It was recently found by Quispe et al[@bib41] that the TG/HDL-C ratio strongly correlated with plasma remnant cholesterol. With regard to sudden death, several postmortem studies reported that RLP levels were significantly elevated[@bib42] and were the strongest predictor of sudden death in cases both with and without evidence of coronary atherosclerosis at autopsy.[@bib31] Given the vasoactive[@bib43] and prothrombotic[@bib44] properties of RLPs, it has been hypothesized that these particles may play a key role in inciting the coronary event that results in sudden death. Some evidence suggests that the proposed residual risk of cardiovascular mortality that persists after achieving recommended targets of LDL-C or TC may be predicted by remnant lipoproteins.[@bib45] In this context, the significantly higher odds of sudden death associated with unit increases in TG/HDL-C ratio (measured at ∼1 year before death) in both univariate and multivariate models lend credence to this evolving hypothesis of how vasoactive remnant particles could act as triggers for fatal cardiac events.

We must note our study's limitations. Of the 399 subjects originally adjudicated as OHSUD cases, only 67.7% (n=270) had medical records. Furthermore, for this study, subject inclusion was limited by the availability of lipid profiles, although cases with and without lipid profiles had similar age, sex, race distributions, and socioeconomic characteristics (data not shown). Reliable electrocardiographic and echocardiographic data were unavailable for most cases and therefore, though relevant to sudden death, were not described.

Although control group subjects were residents of the same county as of cases, they came from a health care system and not a community-based source. The mean age of the control group was also younger than that of controls, which is a potential source of bias. However, we would expect a younger age to bias controls toward even lower LDL-C and TC levels. Comorbid medical conditions were abstracted differently for cases (exact terms abstracted from medical records) and controls (*International Classification of Diseases, Ninth Revision*/*International Statistical Classification of Diseases, 10th Revision* codes). Despite these limitations, we believe that the consistency observed in the differences in mean lipid measurements when compared between the 2 control group populations (Wake county and NHANES participants) increases the reliability of our results.

Conclusion {#sec4}
==========

In this community-based case-control study of nonelderly adults, lower serum TC, LDL-C, and non--HDL-C levels but a higher TG/HDL-C ratio were associated with an increased risk of OHSUD. These findings indicate the need for prospective studies to elucidate the role of lipids in sudden death.

Supplemental Online Material {#appsec1}
============================
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[^1]: BMI = body mass index; LL = lipid-lowering; NHANES = National Health and Nutrition Examination Survey; OHSUD = out-of-hospital sudden unexpected death.

[^2]: Data are presented as mean ± SD or No. (percentage).

[^3]: *P* values reported for comparisons between OHSUD cases and each control group.

[^4]: Missing data: BMI missing for 2 OHSUD cases (1.4%) and 75 local controls (7.7%); dyslipidemia status missing for 1849 NHANES participants (40.5%); use of LL medication missing for 3944 NHANES participants (86.3%); diabetes mellitus status missing for 2 NHANES participants (0.04%); hypertension status missing for 9 NHANES participants (0.2%); coronary artery disease status missing for 277 NHANES participants (6.1%).

[^5]: *P* values for race are reported for only black and white race groups. Dash indicates absence of that particular race classification within the data for that group.

[^6]: *P*\<.001.

[^7]: *P*\<.05.

[^8]: HDL = high-density lipoprotein cholesterol; LDL = low-density lipoprotein cholesterol; NHANES = National Health and Nutrition Examination Survey; OHSUD = out-of-hospital sudden unexpected death; TC = total cholesterol; TG = triglyceride.

[^9]: SI conversion factor: To convert mg/dL values to mmol/L, multiply by 0.0259.

[^10]: Data are presented as mean ± SD.

[^11]: *P* values reported are adjusted for age- and sex-adjusted mean differences in each lipid measure as compared to OHSUD cases.

[^12]: Missing data: TC level missing for 383 NHANES participants (7.7%) and 5 local controls (50%); TG level missing for 2738 NHANES participants (55.3%), 70 local controls (7.2%), and 1 OHSUD case (0.7%); HDL-C level missing for 383 NHANES participants (7.7%), 14 local controls (1.4%), and 1 OHSUD case (0.7%); LDL-C level missing for 2780 NHANES participants (56.1%), 54 local controls (5.6%), and 4 OHSUD cases (2.9%).

[^13]: *P*\<.001.

[^14]: *P*\<.05.

[^15]: HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol; OHSUD = out-of-hospital sudden unexpected death; NHANES = National Health and Nutrition Examination Survey; TC = total cholesterol; TG = triglyceride.

[^16]: Local controls are the reference group.

[^17]: Model 1: unadjusted; model 2: adjusted for age and sex; model 3: adjusted for age, sex, body mass index, diabetes mellitus, and interaction between respective lipid measure and lipid-lowering medication use. For the TG/HDL-C ratio, model 3 adjusts for age, sex, body mass index, and diabetes mellitus. For the LDL-C level and LDL-C/HDL-C ratio, model 3 additionally adjusts for TG level (as continuous variable).
